| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/23/2003 | EP1007032B1 4-cyano-4-deformylsordaricin derivatives |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | EP0964744B1 Method for producing phthalic anhydride; shell catalyst containing titanium-vanadium-cesium |
| 04/23/2003 | EP0915846B1 2- and 2,5-substituted phenylketoenols |
| 04/23/2003 | EP0865423B1 Iminoacetic acid amides and their use as pest control agents |
| 04/23/2003 | CN1413202A Stereospecific hydrolysis of optically active esters |
| 04/23/2003 | CN1106393C Optically active beta-aryl substitution-2 (5H)-ketofuran and its synthesis process |
| 04/23/2003 | CN1106392C Butenolide containing no substituent at beta position and its synthesis process |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552176 Salt forms of 6-n-butylamino-6-deoxy-α-L-sorbofuranose |
| 04/22/2003 | US6552155 Blocked poly(1,4-butanediol)bis(4-aminobenzoate); formulations with polyisocyanates; rapid curing when exposed to water or air humidity; anticorrosive coating, antifouling paint, caulking, sealing, waterproofing |
| 04/22/2003 | US6552086 For therapy of psychiatric and neurological disorders |
| 04/22/2003 | US6552076 Anticarcinogenic agents; controlling apoptosis |
| 04/22/2003 | US6552071 Methods for treating cell death diseases and inflammation |
| 04/22/2003 | US6552065 Antiproliferative agents |
| 04/22/2003 | US6552047 H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use |
| 04/22/2003 | US6552042 Anticoagulants |
| 04/22/2003 | US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels |
| 04/17/2003 | WO2003031427A1 Systems and methods for generation of ascorbic acid with reduced color |
| 04/17/2003 | WO2003031426A1 Succinic anhydride, process for preparation of the same and use thereof |
| 04/17/2003 | WO2003031425A1 Diastereomerically or enantiomerically selective lactonisation |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003031389A1 Abscisic acid biosynthesis inhibitor |
| 04/17/2003 | WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 04/17/2003 | WO2003030889A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | WO2003030812A2 1-[(4-methyl thio)phenyl]-2-(phenyl acetoxy)-1-ethanone and a process for preparing the same |
| 04/17/2003 | WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 04/17/2003 | WO2003006454A3 Heterocyclic carboxamides and their use as fungicides |
| 04/17/2003 | WO2002092564A3 Synthesis of cyclopentadiene derivatives |
| 04/17/2003 | WO2000010990A3 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof |
| 04/17/2003 | US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents |
| 04/17/2003 | US20030073854 Process for ascorbic acids using alkaline earth silicate catalysts |
| 04/17/2003 | US20030073851 Arylphenyl-substituted cyclic ketoenols |
| 04/17/2003 | US20030073847 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/17/2003 | US20030073832 Novel aminophenyl ketone derivatives |
| 04/17/2003 | US20030073745 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
| 04/17/2003 | US20030073727 Central nervous system disorders |
| 04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
| 04/17/2003 | US20030073709 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia |
| 04/17/2003 | US20030070240 N-heteroarylmethyl-p-phnylendiamine derivatives and compounds containing oxidationcoloring agents |
| 04/17/2003 | CA2462689A1 Inhibitor against biosynthesis of abscisic acid |
| 04/17/2003 | CA2462301A1 Para-amino benzoic acids as integrin antagonists |
| 04/16/2003 | EP1302470A1 Lipid-rich plaque inhibitors |
| 04/16/2003 | EP1302469A1 Process for producing hydroxylactone |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1301502A1 Novel compounds and their use as glycine transport inhibitors |
| 04/16/2003 | EP1301501A1 Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect |
| 04/16/2003 | EP1301474A2 Tyrosine derivatives as phosphatase inhibitors |
| 04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |
| 04/16/2003 | EP1173431B1 Method for the preparation of citalopram |
| 04/16/2003 | CN1411454A Method for preparation of citalopram |
| 04/16/2003 | CN1411451A Method for production of 1,3-disubstituted 2-nitroguanidines |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
| 04/16/2003 | CN1410422A Benzfuran compound |
| 04/16/2003 | CN1410161A Catalyst used in furfural gaseous phase hydrogenation to prepare furyl alcohol and its preparation method |
| 04/15/2003 | US6548713 Process for the preparation of organic compounds with manganese catalysts or the like |
| 04/15/2003 | US6548699 4,4*-(Isopropylidenedithio)-(2*,6*-di-tert-butylphenol)-(2,6-d i-tert-butylphenol-O*-acetic acid); antiarthritic, antiinflammatory agents; rheumatic and cardiovascular disorders |
| 04/15/2003 | US6548694 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548549 Fungicides, insecticides, bactericides; applying to plant |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548546 HIV integrase inhibitors |
| 04/15/2003 | US6548539 Aliphatic cyclic or heterocyclic compounds substituted with amido or urea groups and either ether or sulfide groups; treating cancer, cardiovascular disorders, skin disorders, osteoporosis, and arthritis |
| 04/15/2003 | US6548538 Potent peroxisome proliferator activated receptor (PPAR)-alpha-activating compounds; propionic acid 2-subsituted with an N-(phenylaminocarbonylalkyl), N-(2-furanylmethyl)aminoalkylphenyl group |
| 04/15/2003 | US6548534 Hydroxy and amine or amide compounds with substitution pattern on the aryl radical; can be used alone or in combination with estrogens in contraceptive preparations for treating gynecological disorders and premenstrual symptoms |
| 04/15/2003 | US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity |
| 04/15/2003 | US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 04/15/2003 | US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives |
| 04/15/2003 | US6547841 Reacting sterically hindered nitroxyl compound with diazonium salt of aromatic amine compound in presence of transition metal catalyst |
| 04/15/2003 | CA2278988C An efficient synthesis of furan sulfonamide compounds useful in the synthesis of new il-1 inhibitors |
| 04/15/2003 | CA2097715C Indan derivatives |
| 04/15/2003 | CA2051504C 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors |
| 04/15/2003 | CA2037975C 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
| 04/10/2003 | WO2003029239A1 Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | WO2003029236A1 Process for the preparation of citalopram |
| 04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029213A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
| 04/10/2003 | WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 04/10/2003 | US20030069393 Compound for use in the treatment of cancer and prevention of infections |
| 04/10/2003 | US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them |
| 04/10/2003 | US20030069304 Antidepressants |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069250 Anticoagulants |
| 04/10/2003 | US20030069242 3-arylphenyl sulfide derivative and insecticide and miticide |
| 04/10/2003 | US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease |
| 04/10/2003 | US20030069225 Synthesis of taxol enhancers |
| 04/10/2003 | US20030069224 Non-nucleoside reverse transcriptase inhibitors |
| 04/10/2003 | US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses. |
| 04/10/2003 | US20030069218 Iron compounds, compositions , methods of making the same and uses thereof |
| 04/10/2003 | US20030068561 Nonaqueous electrolytic solution and secondary battery containing the same |
| 04/10/2003 | US20030068261 Exothermic reactions; uniform cross-section |
| 04/10/2003 | US20030066988 Electroconductivity coloring |